News

  • All
  • Announcements
  • Blog Posts
  • Media Highlights
  • Press Releases

07.26.2021

Absci Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

07.22.2021

A Message from Absci’s CEO

07.22.2021

TechCrunch: Shares of protein discovery platform Absci pop in market debut

07.22.2021

FOX Business: CEO of synthetic biotech company Absci on Nasdaq debut

07.21.2021

Absci Announces Pricing of Initial Public Offering

07.07.2021

Absci Strengthens Executive Leadership Team with Strategic Hires to Support Business Growth

06.30.2021

Absci Announces Filing of Registration Statement for Proposed Initial Public Offering

06.17.2021

Contract Pharma: AbSci Acquires Cell Therapy Company Totient

06.14.2021

AbSci Announces Acquisition of Target Discovery Company Totient

Find out more

Contact Us

Translate ideas into impact

Explore current openings and get ready to prove that impossible isn’t.

Unlimit with us

© Copyright 2021 Absci Corp